Evidence map›Paper›PMID 22067657›Full record

ArticleCell cycle (Georgetown, Tex.)2011

Effects of conditional depletion of topoisomerase II on cell cycle progression in mammalian cells.

Ruth E Gonzalez, Chang-Uk Lim, Kelly Cole, Christine Hanko Bianchini, Gary P Schools, Brian E Davis, Ikuo Wada, Igor B Roninson, Eugenia V Broude

Open access · greenAbstract read
In one paragraph

Article in Cell cycle (Georgetown, Tex.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. SUMO: A Swiss Army Knife for Eukaryotic Topoisomerases.Frontiers in molecular biosciences · 2022
    Review
  5. Topoisomerase IIα is essential for maintenance of mitotic chromosome structure.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  6. Biological evaluation of novel thiomaltol-based organometallic complexes as topoisomerase IIα inhibitors.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  7. Review
  8. Review
  9. Article
  10. TOP2B: The First Thirty Years.International journal of molecular sciences · 2018
    Review
  11. A Topology-Centric View on Mitotic Chromosome Architecture.International journal of molecular sciences · 2017
    Review
  12. Physiological Roles of DNA Double-Strand Breaks.Journal of nucleic acids · 2017
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. DNA Topoisomerases.EcoSal Plus · 2015
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Ruth E GonzalezCancer Center, Ordway Research Institute, Albany, NY, USA.
Chang-Uk Lim
Kelly Cole
Christine Hanko Bianchini
Gary P Schools
Brian E Davis
Ikuo Wada
Igor B Roninson
Eugenia V Broude
Albany Research Institute · USColumbia College - South Carolina · USUniversity of South Carolina · US

Funding

Secretory Patterns of Senescent Tumor CellsR01AG028687 · NIA · UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA · PI RONINSON, IGOR B · 2007 to 2011
$1.6M
Mitotic Catastrophe in Tumor CellsR01CA095727 · NCI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI RONINSON, IGOR B · 2002 to 2005
$1.2M
NCI NIH HHS R01 CA095727NCI NIH HHS R01 CA95727NIA NIH HHS R01 AG028687
6 · The paper itself

Abstract

Topoisomerase II (Topo II) that decatenates newly synthesized DNA is targeted by many anticancer drugs. Some of these drugs stabilize intermediate complexes of DNA with Topo II and others act as catalytic inhibitors of Topo II. Simultaneous depletion of Topo IIα and Topo IIβ, the two isoforms of mammalian Topo II, prevents cell growth and normal mitosis, but the role of Topo II in other phases of mammalian cell cycle has not yet been elucidated. We have developed a derivative of p53-suppressed human cells with constitutive depletion of Topo IIβ and doxycycline-regulated conditional depletion of Topo IIα. The effects of Topo II depletion on cell cycle progression were analyzed by time-lapse video microscopy, pulse-chase flow cytometry and mitotic morphology. Topo II depletion increased the duration of the cell cycle and mitosis, interfered with chromosome condensation and sister chromatid segregation and led to frequent failure of cell division, ending in either cell death or restitution of polyploid cells. Topo II depletion did not change the rate of DNA replication but increased the duration of G 2. These results define the effects of decreased Topo II activity, rather than intermediate complex stabilization, on the mammalian cell cycle.

Indexed as

AnimalsCell CycleCell LineCells, CulturedDNA PrimersDNA Topoisomerases, Type IIDoxycyclineFlow CytometryHumansImmunoenzyme TechniquesIndolesMicroscopy, FluorescenceTime-Lapse ImagingDAPIDNA PrimersDNA Topoisomerases, Type IIDoxycyclineIndoles

Identifiers

PMID22067657
PMCPMC3356834
OpenAlexW2146423725

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.